ContraFect Corporation (CFRXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -56.88 Million USD | -20.36% |
| 2021 | -47.26 Million USD | -38.04% |
| 2020 | -34.23 Million USD | -22.87% |
| 2019 | -27.86 Million USD | 13.85% |
| 2018 | -32.34 Million USD | -21.77% |
| 2017 | -26.56 Million USD | 20.78% |
| 2016 | -33.53 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -7.97 Million USD | 9.97% |
| 2023 Q3 | -6.67 Million USD | 16.28% |
| 2023 Q1 | -8.85 Million USD | -32.15% |
| 2022 Q1 | -15.97 Million USD | -13.48% |
| 2022 Q3 | -14.18 Million USD | 29.19% |
| 2022 Q4 | -6.7 Million USD | 52.73% |
| 2022 Q2 | -20.02 Million USD | -25.33% |
| 2022 FY | -56.88 Million USD | -20.36% |
| 2021 Q3 | -11.68 Million USD | 0.0% |
| 2021 FY | -47.26 Million USD | -38.04% |
| 2021 Q4 | -14.08 Million USD | -20.49% |
| 2020 FY | -34.23 Million USD | -22.87% |
| 2019 FY | -27.86 Million USD | 13.85% |
| 2018 FY | -32.34 Million USD | -21.77% |
| 2017 FY | -26.56 Million USD | 20.78% |
| 2016 FY | -33.53 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HST Global, Inc. | -140.9 Thousand USD | -40273.438% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -8181.389% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -33069.583% |
| CytoDyn Inc. | -18.05 Million USD | -215.035% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 3.562% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| MultiCell Technologies, Inc. | -722.81 USD | -7870433.058% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -3032.102% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -1027.747% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -189833.894% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -31246.392% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Cognition Inc. | -9.7 Million USD | -486.146% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -2.488% |
| SQZ Biotechnologies Company | -75.82 Million USD | 24.973% |
| Resverlogix Corp. | -12.74 Million USD | -346.223% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -14503.024% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 683.929% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -2216.972% |
| Mesoblast Limited | -84.14 Million USD | 32.393% |
| GB Sciences, Inc. | -1.42 Million USD | -3904.832% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -8181.389% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -218.759% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -1570.759% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -755.729% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -1695.583% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -1968.06% |
| BioStem Technologies, Inc. | -7.77 Million USD | -631.318% |
| LadRx Corporation | -3.82 Million USD | -1387.829% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -258.475% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -4983.914% |
| CSL Limited | 3.7 Billion USD | 101.537% |
| Biomind Labs Inc. | -1 Million USD | -5534.789% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -6008.033% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 169.502% |
| Nascent Biotech, Inc. | -2.22 Million USD | -2451.215% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 20.752% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 1257.501% |
| GeneThera, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 1707.034% |
| Adynxx, Inc. | - USD | Infinity% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -3603.593% |
| Marizyme, Inc. | -34.08 Million USD | -66.896% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -581.305% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -9973.788% |
| Zenith Capital Corp. | -8.94 Million USD | -536.129% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -1895.75% |
| Halberd Corporation | -75.05 Thousand USD | -75701.466% |
| Genus plc | 6.4 Million USD | 988.891% |
| Pharming Group N.V. | -4.87 Million USD | -1065.867% |
| MetaStat, Inc. | - USD | Infinity% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -2763.811% |
| IMV Inc. | -38.67 Million USD | -47.108% |
| Affymax, Inc. | -15.04 Million USD | -278.1% |
| SYBLEU INC | -149.18 Thousand USD | -38034.468% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -5349.138% |
| Enzolytics Inc. | -2.14 Million USD | -2547.478% |
| argenx SE | -425.04 Million USD | 86.616% |
| AVAX Technologies, Inc. | 6.69 Million USD | 949.993% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -3957.729% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -4159.973% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -1418.49% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -225919.07% |
| Cell Source, Inc. | -4.32 Million USD | -1215.247% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -11676.749% |
| Q BioMed Inc. | -3.44 Million USD | -1551.055% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -1242.224% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -4429.379% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -2065.12% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -1149.01% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -3.487% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -1860.844% |
| Rebus Holdings, Inc. | -664 Thousand USD | -8467.62% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -5681.091% |
| Skye Bioscience, Inc. | -13.67 Million USD | -316.105% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -2951.379% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -2737.701% |
| ONE Bio Corp. | 13.68 Million USD | 515.808% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -2843.636% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -4957.223% |
| Agentix Corp. | -1.37 Million USD | -4047.166% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -1848.624% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -3502.04% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -326454.159% |
| Kadimastem Ltd | -3.04 Million USD | -1771.195% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -21636.09% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -13592.389% |
| NovAccess Global Inc. | -2.46 Million USD | -2206.224% |
| Itoco Inc. | -919.14 Thousand USD | -6089.373% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -25749.472% |
| Qrons Inc. | -643.67 Thousand USD | -8738.128% |
| Mobile Lads Corp. | -554.55 Thousand USD | -10158.588% |
| Genscript Biotech Corporation | -415.79 Million USD | 86.318% |
| International Stem Cell Corporation | -663 Thousand USD | -8480.543% |
| Bioxytran, Inc. | -3.82 Million USD | -1389.184% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -107971.809% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -279590.265% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -56.866% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -3416.007% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -7631.217% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -1728.64% |
| Neutra Corp. | -229.48 Thousand USD | -24689.748% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -224.357% |
| PureTech Health plc | -146.19 Million USD | 61.088% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -164.709% |
| IXICO plc | -1.43 Million USD | -3858.873% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -499.399% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 53.295% |
| CSL Limited | 3.81 Billion USD | 101.492% |
| Cellectis S.A. | -108.85 Million USD | 47.74% |